Go Pro
NYSE:CAH

Cardinal Health (CAH) Stock Price, News & Analysis

Cardinal Health logo
$230.18 +3.11 (+1.37%)
Closing price 03:59 PM Eastern
Extended Trading
$229.12 -1.06 (-0.46%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cardinal Health Stock (NYSE:CAH)

Advanced

Key Stats

Today's Range
$225.39
$231.23
50-Day Range
$194.96
$239.36
52-Week Range
$137.75
$243.21
Volume
1.74 million shs
Average Volume
2.03 million shs
Market Capitalization
$53.91 billion
P/E Ratio
35.20
Dividend Yield
0.89%
Price Target
$251.73
Consensus Rating
Moderate Buy

Company Overview

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions. Cardinal Health also offers specialty services for pharmacies and health systems, including medication management, nuclear pharmacy services, clinical product offerings and solutions designed to improve operational efficiency. Its product portfolio spans consumables such as gloves and surgical supplies to capital equipment, diagnostic and laboratory products, and software-enabled supply chain services.

Cardinal Health serves customers across the United States and in international markets, delivering products and services through an extensive distribution network and logistics infrastructure. The company supports a broad set of healthcare stakeholders — from independent and chain pharmacies to large health systems and manufacturers — and emphasizes integrated supply chain solutions, regulatory compliance and operational support. Cardinal Health is managed by an executive leadership team and governed by a board of directors focused on delivering healthcare supply chain services and innovation for its clients.

AI Generated. May Contain Errors.

Cardinal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

CAH MarketRank™: 

Cardinal Health scored higher than 93% of companies evaluated by MarketBeat, and ranked 42nd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on no strong buy ratings, 15 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Cardinal Health is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Cardinal Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Cardinal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Cardinal Health are expected to grow by 11.79% in the coming year, from $10.77 to $12.04 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardinal Health is 35.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardinal Health is 35.20, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 281.83.

  • Price to Earnings Growth Ratio

    Cardinal Health has a PEG Ratio of 1.12. PEG Ratios above 1 indicate that a company could be overvalued.

  • Read more about Cardinal Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.88% of the float of Cardinal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardinal Health has a short interest ratio ("days to cover") of 2.63, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardinal Health has recently decreased by 4.59%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cardinal Health has a dividend yield of 0.90%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Cardinal Health has been increasing its dividend for 29 years.

  • Dividend Coverage

    The dividend payout ratio of Cardinal Health is 31.50%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 17.11% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

  • Read more about Cardinal Health's dividend.
  • News Sentiment

    Cardinal Health has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 21 news articles for Cardinal Health this week, compared to 7 articles on an average week.
  • Search Interest

    Only 20 people have searched for CAH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    20 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 186% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardinal Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.12% of the stock of Cardinal Health is held by insiders.

  • Percentage Held by Institutions

    87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardinal Health's insider trading history.
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAH Stock News Headlines

McKesson distribution facility exterior at dusk, showing branded trucks at loading docks and a glass-walled warehouse interior.
McKesson's Compounding Keeps Adding Up (CAH)
McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix.
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

CAH Stock Analysis - Frequently Asked Questions

Cardinal Health's stock was trading at $205.62 at the beginning of the year. Since then, CAH stock has increased by 11.9% and is now trading at $230.18.

Cardinal Health, Inc. (NYSE:CAH) posted its quarterly earnings data on Thursday, April, 30th. The company reported $3.17 earnings per share for the quarter, topping analysts' consensus estimates of $2.79 by $0.38. The firm's revenue was up 11.0% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Cardinal Health: Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and more.

Cardinal Health's top institutional investors include Wedge Capital Management L L P NC (0.06%), Handelsbanken Fonder AB (0.06%), PensionDanmark Pensionsforsikringsaktieselskab (0.04%) and Kwmg LLC (0.03%). Insiders that own company stock include Jason M Hollar, Jessica L Mayer, Aaron E Alt, Deborah Weitzman, Stephen M Mason, Ola M Snow, Michelle D Greene and Mary C Scherer.
View institutional ownership trends
.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), ExxonMobil (XOM), Broadcom (AVGO), AbbVie (ABBV) and Chevron (CVX).

Company Calendar

Last Earnings
4/30/2026
Record date for 7/15 Dividend
7/01/2026
Ex-Dividend for 7/15 Dividend
7/01/2026
Dividend Payable
7/15/2026
Today
7/31/2026
Next Earnings (Estimated)
8/11/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NYSE:CAH
CIK
721371
Employees
57,700
Year Founded
1971

Price Target and Rating

High Price Target
$275.00
Low Price Target
$208.00
Potential Upside/Downside
+9.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$6.54
Trailing P/E Ratio
35.20
Forward P/E Ratio
21.37
P/E Growth
1.12
Net Income
$1.56 billion
Net Margins
0.62%
Pretax Margin
0.80%
Return on Equity
-92.61%
Return on Assets
4.46%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.91
Quick Ratio
0.48

Sales & Book Value

Annual Sales
$222.58 billion
Price / Sales
0.24
Cash Flow
$11.72 per share
Price / Cash Flow
19.64
Book Value
($11.04) per share
Price / Book
-20.85

Miscellaneous

Outstanding Shares
234,210,000
Free Float
233,925,000
Market Cap
$53.91 billion
Optionable
Optionable
Beta
0.49

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:CAH) was last updated on 7/31/2026 by MarketBeat.com Staff.
From Our Partners